Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Associatie tussen decompensatio cordis en darmkanker
aug 2018 | Hartfalen, Maag-darm-leveroncologie